MeSH term
Frequency | Condition_Probility | Animals | 22 | 0.0 |
Humans | 47 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Receptors, Formyl Peptide | 29 | 42.0 |
Receptors, Immunologic/*immunology | 3 | 2.0 |
*Receptors, Lipoxin | 30 | 88.0 |
Receptors, Peptide/*immunology | 3 | 100.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Calcium/metabolism | 11 | 0.0 |
Chemotactic Factors/*immunology | 3 | 37.0 |
Male | 2 | 0.0 |
Rats | 8 | 0.0 |
Signal Transduction/immunology | 2 | 0.0 |
Virulence Factors, Bordetella/pharmacology | 3 | 1.0 |
Receptors, Immunologic/metabolism | 3 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Cell Line | 11 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Endocytosis/drug effects | 3 | 4.0 |
GTP-Binding Proteins/*metabolism | 3 | 0.0 |
Oligopeptides/pharmacology | 2 | 1.0 |
Receptors, Immunologic/*physiology | 2 | 1.0 |
Receptors, Peptide/*physiology | 2 | 22.0 |
Time Factors | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Chemotaxis, Leukocyte | 2 | 1.0 |
In Vitro | 3 | 0.0 |
NADPH Oxidase/metabolism | 3 | 6.0 |
Receptors, Immunologic/immunology | 2 | 1.0 |
Receptors, Peptide/immunology | 2 | 100.0 |
Indicators and Reagents | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 6 | 0.0 |
Phosphorylation | 7 | 0.0 |
Receptors, Formyl Peptide/*metabolism | 2 | 100.0 |
Signal Transduction | 3 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Mice | 5 | 0.0 |
Transfection | 8 | 0.0 |
HIV-1/drug effects/physiology | 2 | 12.0 |
Gene Expression | 3 | 0.0 |
Monocyte Chemoattractant Proteins/*pharmacology | 2 | 40.0 |
Oligopeptides/*pharmacology | 6 | 7.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Chemotaxis/drug effects | 2 | 2.0 |
Ligands | 8 | 0.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Superoxides/metabolism | 3 | 1.0 |
HL-60 Cells | 2 | 0.0 |
Chemotaxis, Leukocyte/*immunology | 2 | 4.0 |
Comparative Study | 3 | 0.0 |
Enzyme Activation/immunology | 2 | 1.0 |
Phagocytes/*immunology | 2 | 6.0 |
Chemotaxis, Leukocyte/physiology | 2 | 10.0 |
Cell Movement/drug effects | 2 | 0.0 |
N-Formylmethionine Leucyl-Phenylalanine/pharmacology | 5 | 1.0 |
Receptors, Immunologic/genetics/*metabolism | 2 | 5.0 |
Receptors, Peptide/genetics/*metabolism | 2 | 18.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Calcium Signaling | 2 | 2.0 |
*Receptors, Formyl Peptide | 2 | 33.0 |
Respiratory Burst/drug effects | 2 | 6.0 |
Chemotaxis, Leukocyte/immunology | 3 | 5.0 |
Monocytes/immunology | 2 | 0.0 |
Neutrophils/immunology | 2 | 1.0 |
Neutrophils/physiology | 2 | 1.0 |
HIV-1/*immunology | 2 | 0.0 |
Adult | 2 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Chemotaxis/*physiology | 2 | 5.0 |
Phagocytes/*metabolism | 2 | 11.0 |
Peptide Fragments/immunology | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Receptors, Immunologic/*genetics | 3 | 2.0 |
Receptors, Peptide/*genetics | 3 | 13.0 |
Up-Regulation | 2 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
*Lipoxins | 2 | 20.0 |
